News
$2.17b AI surge projected by 2034 amidst pursuit to end missed cancer diagnoses
$2.17b AI surge projected by 2034 amidst pursuit to end missed cancer diagnoses
Asia-Pacific drives the fastest growth.
Coronary artery disease, lifestyle factors boost cardiology device growth
Catheter-based procedures are preferred over traditional surgery.
NSW’s St George Hospital building centralises outpatient, community services
It is scheduled to open in the coming months.
China captures 49% of global drug deals in 2025 amidst lower costs, faster timelines
This is an improvement from only 6% in 2020.
Strong pipeline, M&A activity could trigger rapid earnings for Greater China's healthcare firms: UOB
The industry is expected to become a key international player.
Chronic diseases, ageing population fuel medical gas market growth
Chronic diseases like COPD, asthma, and cancer are rising.
AI patient engagement market hits $33.68b by 2032
The report projects 20.9% annual growth as cloud deployments dominate due to lower costs.
India’s Bio Pharma Shakti scheme signals end of import reliance
The national initiative targets drug affordability and R&D expansion.
Ageing populations drive ophthalmic disease strain on APAC healthcare
Chronic vision conditions are also adding pressure on hospitals and clinics.
Australia launches ‘Open Science Policy’ for health research
Data, methods, software, and code should be shared openly.
IHH Healthcare expands cancer treatment with new radiotherapy investment
It delivers radiation 400 times faster than existing methods.
Pharmacy automation devices market to reach $9.83b by 2028
Steady growth projected for global automation systems.
Healthway Cancer Care Hospital strengthens IV safety with global programme
It is the first specialty hospital in Southeast Asia to finish the initiative.
AI training targets 50,000 doctors in India to strengthen medical skills
Over 42,000 doctors have already registered.
Japan leads Asia with 24 FDA novel-drug approvals: McKinsey
Regulatory fast-track supports global approvals, McKinsey says
India biopharma pipeline jumps to 450 assets from 270: McKinsey
McKinsey said India has more than 2,050 WHO GMP-certified sites.
South Korea secures $4.2b biologics deals as advanced biopharma activity expands
Licensing, funding, and IPO activity support sector development
Most Read
1. Agentic AI cuts drug development timelines: report 2. Biopharma firms face $275b patent cliff as returns stall 3. iX Biopharma secures $52.8m US contract for pain reliever trials 4. DBS’ $72m loan to PLife REIT to finance elder care in Japan 5. Aging population drives demand for durable medical equipment marketResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
